Dr. Smitha’s primary interest is in haemato oncology & bone marrow transplantation (BMT).
She also has interest in treating paediatric tumours.
Her expertise lies mainly in treating breast cancer, leukemias, lymphomas, multiple myeloma, gastrointestinal cancers, genitourinary cancers, head & neck cancers and lung cancers.
Dr. Smitha attends over 5000 cases every year.
Training and Certifications
ESMO exam for medical oncologists from the European Society of Medical Oncology in 2017
Fellowship training in Bone Marrow Transplantation in 2019
NITTE Education Trust Award – Gold Medal andHighest marks in Community Medicine, RGUHS, 2003
NITTE Education Trust Award – Gold Medal andHighest marks in ENT, RGUHS, 2003.
ESMO ASIA 2015 ISMPO travel grant at ISMPOCON, Mumbai, Nov 2015.
Best Poster Award at the ISMPOCON, Mumbai, Nov 2015.
Pfizer grant for Research Hypothesis presentation at ISMPOCON Nov 2016.
RCC Perceptorship programme at Taiwan
ESMO Preceptorship on Metastatic Bladder and Kidney Cancer - Multidisciplinary management, standards of care, therapeutic targets and future perspectives, 19-20 September 2018, Singapore.
ESMO Preceptorship on Non-Small-Cell Lung Cancer - Standards of care, evolving paradigm and future perspectives, 21-22 November 2018, Singapore.
ESMO Preceptorship on Immuno-Oncology - From the essentials of tumour immunology to clinical application,26-27 November 2018, Singapore
Presentation at ESMO Congress 2019 at Spain
IASLC WCLC 2019 at Spain
Study on Awareness among School Children on the spread, symptoms, treatment and prevention of Malaria in an urban endemic area of South India. Karnataka Paediatric Journal, 24 (1), January-March 2010: p 4-6
A Study on the Awareness observed among Individuals living in Endemic Area on the Spread, Symptoms, Treatment and prevention of Malaria. Al Ameen J Med Sci 4 (1), January-March 2011: p 80-83
An Interesting Case Report on Cerebellar and Psychiatric Manifestations in Malaria. Journal of Clinical and Diagnostic Research, October 2011, 5 (5): 1104-6
Extermination of the Smallpox Virus – Light at the End of the Tunnel… or not – the Stalemate Continues. Annals of Community Health, 2014 Apr; 2 (2): 2-3.
Langerhans Cell Sarcoma – Review of Literature and a Rare Case Report . J Mol BiomarkDiagn2014; 5:181.
Plasmablastic lymphoma of bone in a human immunodeficiency virus positive child – A rare extra-oral presentation. Pediatric Infectious Disease, 2014; 6 (4), 142 – 144
Epigenetic therapy of cancer with histonedeacetylase inhibitors. Journal of Cancer Research and Therapeutics, 2014; 10 ( 3): 469-478
A study of comparison of prognostic models in peripheral T cell lymphoma in a tertiary care centre in South India. Annals of Oncology 26 (Supplement 9): ix85–ix92, 2015
The Efficacy, safety and cost benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: a pilot study from south India. Chemotherapy Research and Practice, vol. 2016, Article ID 3439707, 2016.
Hairy Cell Leukemia – Clinical Profile and treatment outcome from a tertiary regional cancer institute in South India. Clin Cancer InvestigJ, 2016; 5:141-5.
Breast cancer as second malignant neoplasm after acute myeloid leukemia: A rare occurence.Clin Cancer investig J, 2016; 333-5.
Gemcitabine – induced supraventricular tachycardia: A rare manifestation. Clin Cancer Investig J 2016; 5:200-2.
Clinicopathological profile of pure Neuroendocrineneoplasms of the Esophagus: A South Indian center experience. Journal of Oncology 2016.
Myelomatous pleural effusion: A rare case entity reported from a tertiary care cancer center in South India. Lung India?: Official Organ of Indian Chest Society. 2017;34(2):176-178.
Diffuse large B-cell lymphoma in elderly: Experience from a tertiary care oncology center in South India. South Asian Journal of Cancer, 2017. 6 (2); 72-74
Role Of Taxanes In Triple-Negative Breast Cancer: A Study From Tertiary Cancer Center In South India. World Journal of Oncology, 2017. 8(4): 110-116.
Patterns and the Occurrence of KRAS Mutations in Metastatic Colorectal Cancers—a Study from Indian Regional Cancer Centre. Indian J SurgOncol (2017) 8: 511.
Role of prephase treatment prior to definitive chemotherapy in diffuse large B -cell lymphoma (DLBCL). Annals of Oncology 28 (Supplement 5), 2017: 361-61
Primary breast angiosarcoma - a single institution experience from a tertiary cancer center in South India. Breast Dis. 2017 Dec 28.
Clinical profile and outcomes of carcinoma anal canal: A single institution experience. Annals of Oncology (2017) 28 (suppl 10): x57-x76.
290PExtranodal NK/T cell lymphoma- nasal type: Experience from an Indian regional cancer centre, November 2018Annals of Oncology 29(suppl_9),
Role of prephase treatment prior to definitive chemotherapy in patients with diffuse large B-cell lymphoma. Eur J Haematol. 2018; 100: 644– 648.
Primary gastrointestinal diffuse large B-cell lymphoma: A prospective study from South India, South Asian Journal of Cancer, 10.4103/sajc.sajc_52_18, 8, 1, (57), (2019).
Primary adrenal leiomyosarcoma: An extremely rare mesenchymal tumor, January 2019Indian journal of medical and paediatric oncology 40(4):559.
Induction Related Mortality in Acute Myeloid Leukemia: Multivariate Model of Predictive Score from the Indian Acute Leukemia Research Database (INwARD) of the Hematology Cancer Consortium (HCC), Blood, Nov 2019.
EP1.14-32 Pattern of EGFR Mutations and Response to First Generation EGFR TKIs in Patients of Metastatic Lung Cancer at a Tertiary Care Centre in India, Journal of Thoracic Oncology, Oct 2019
Clinico-epidemiological profile of Neuroendocrine tumors from a tertiary regional cancer institute in India – Accepted for publication in Indian Journal of Cancer
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.